Shares of WELL Health Technologies Corp. (TSE:WELL - Get Free Report) reached a new 52-week high on Tuesday after Royal Bank of Canada raised their price target on the stock from C$7.00 to C$8.50. The company traded as high as C$7.30 and last traded at C$7.23, with a volume of 1354392 shares changing hands. The stock had previously closed at C$6.95.
A number of other research firms have also weighed in on WELL. Haywood Securities increased their target price on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th. Ventum Financial reduced their price target on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a research note on Tuesday, October 29th. Scotiabank upped their target price on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday, December 16th. CIBC boosted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Finally, TD Securities lifted their target price on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday, December 17th.
Read Our Latest Stock Analysis on WELL Health Technologies
WELL Health Technologies Stock Performance
The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The firm's fifty day moving average is C$5.94 and its 200 day moving average is C$5.03. The company has a market cap of C$1.81 billion, a PE ratio of 12.74, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Stories
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
